ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Financial toxicity among breast cancer survivors receiving care during the pandemic.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo appraise financial toxicity (FT) among women receiving care for breast cancer during the COVID-19 pandemic and determine sociodemographic, clinical, psychosocial, and care-disruption factors linked to greater financial hardship.
methodsForty-eight survivors (mean age = 45.3 ± 10.9 years; 42% Black, 42% non-Hispanic White, 17% Hispanic/Latina) completed an online survey. FT was measured with the COST-FACIT. Additional instruments assessed perceived stress (PSS-10), coping (Brief-COPE), self-efficacy (CBI-B), social isolation (PROMIS-SF-4a), health-related quality of life (FACT-B), and pandemic-related delays or changes in cancer care. Pearson correlations explored bivariate associations; backward-selection regression identified predictors of FT.
resultsMean COST score was 21.77 ± 12.33 and 58.3% of survivors met the threshold for mild or moderate FT (< 26). Worse FT correlated with higher psychological distress (p = 0.001), greater social isolation (p = 0.005), and more care disruptions (p < 0.001). Financial security correlated with greater self-efficacy (p = 0.019) and higher health-related quality of life (p < 0.001). In multiple regression analysis (R
conclusionsBreast cancer survivors experienced substantial FT while navigating care during the pandemic, with greater burden associated with psychological distress, social isolation, care disruptions, and lower socioeconomic status. FT was attenuated among those with higher health-related quality of life and self-efficacy. Integrating proactive financial navigation, psychosocial screening, and targeted support for socioeconomically vulnerable survivors into routine oncology care may mitigate financial hardship and improve overall well-being.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.